Correlation Between Eurobio Scientific and Virbac SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eurobio Scientific and Virbac SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eurobio Scientific and Virbac SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eurobio Scientific SA and Virbac SA, you can compare the effects of market volatilities on Eurobio Scientific and Virbac SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eurobio Scientific with a short position of Virbac SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eurobio Scientific and Virbac SA.

Diversification Opportunities for Eurobio Scientific and Virbac SA

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Eurobio and Virbac is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Eurobio Scientific SA and Virbac SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virbac SA and Eurobio Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eurobio Scientific SA are associated (or correlated) with Virbac SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virbac SA has no effect on the direction of Eurobio Scientific i.e., Eurobio Scientific and Virbac SA go up and down completely randomly.

Pair Corralation between Eurobio Scientific and Virbac SA

Assuming the 90 days trading horizon Eurobio Scientific SA is expected to generate 0.35 times more return on investment than Virbac SA. However, Eurobio Scientific SA is 2.88 times less risky than Virbac SA. It trades about -0.07 of its potential returns per unit of risk. Virbac SA is currently generating about -0.25 per unit of risk. If you would invest  2,580  in Eurobio Scientific SA on August 30, 2024 and sell it today you would lose (20.00) from holding Eurobio Scientific SA or give up 0.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eurobio Scientific SA  vs.  Virbac SA

 Performance 
       Timeline  
Eurobio Scientific 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Eurobio Scientific SA are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Eurobio Scientific is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Virbac SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virbac SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Virbac SA is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eurobio Scientific and Virbac SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eurobio Scientific and Virbac SA

The main advantage of trading using opposite Eurobio Scientific and Virbac SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eurobio Scientific position performs unexpectedly, Virbac SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virbac SA will offset losses from the drop in Virbac SA's long position.
The idea behind Eurobio Scientific SA and Virbac SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments